STIMULIVER
Stimuliver is a biotechnology company developing a 3D liver implant to treat critically failing liver function. The company was founded in 2021 and is based in Copenhagen, Denmark.
STIMULIVER
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2021-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.stimuliver.bio
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Office 365 Mail Pound Sterling Squarespace Hosted GoDaddy Email NSONE
Similar Organizations
ARNA Genomics
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
Dispendix
Dispendix is a biotechnology company that specializes in single-cell printing.
Hexis Lab
Hexis Lab is a technology company working at the forefront of raw material innovation.
Olfactomics
Olfactomics is a Finnish university-based spinoff company developing a novel technology for surgical tissue assessment.
Sotio
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Suri Biotech
Suri Biotech is a biotechnology company developing health-promoting bacterial strains with unique mechanisms.
Investors List
BioInnovation Institute
BioInnovation Institute investment in Convertible Note - Stimuliver
Official Site Inspections
http://www.stimuliver.bio
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "Stimuliver"
About us — Stimuliver
Stimuliver is committed to supporting severly ill liver patients with a regenerative rescue treatment that is independent of donors. Our goal is to provide a groundbreaking alternative for …See details»
What we do - Stimuliver
Stimuliver safely supplements the liver’s functioning through a remote implant, which helps filter toxins and take the burden off the liver. It’s a radically different approach, which bypasses the …See details»
Meet the start-ups: Stimuliver - BioInnovation Institute
Oct 7, 2021 Bio Studio. Establishes spin-out companies based on transformative research. Bio Studio. Venture Lab. Empowering founders to launch impactful start-ups. Open call. ... “Stimuliver is built on world-class research, and we are …See details»
Stimuliver - Crunchbase Company Profile & Funding
Stimuliver is a biotechnology company developing a 3D liver implant to treat critically failing liver function. The company was founded in 2021 and is based …See details»
Liver implant start-up Stimuliver launched | News
A new company developing liver implants to treat patients with critical failing livers has been launched based on research from Professor David Hay’s labs at the University of Edinburgh’s Centre for Regenerative Medicine on Edinburgh …See details»
Stimuliver - LinkedIn
Stimuliver announces senior cell therapy executive to be joining the board. Copenhagen, Denmark, 2024 – Stimuliver APS is an emerging biotech company developing a first-in-class tissue implant ...See details»
Stimuliver - The Index Project
Stimuliver is developing disruptive liver implant technology to treat critically failing liver function in humans. Many people suffer from chronic liver disease. By supporting the liver with our 3D implants, it will help patients sustain critical …See details»
Stimuliver ApS - Drug pipelines, Patents, Clinical trials - Synapse
Explore Stimuliver ApS with its drug pipeline, therapeutic area, technology platform, .See details»
Spinout Stimuliver receives £1.7m for new
The Denmark-based spinout has received DKK 15m (£1.7m) from the BioInnovation Institute (BII) and Vaekstfonden, Denmark’s state investment fund.. Stimuliver is developing a treatment for liver diseases using liver tissue …See details»
Stimuliver - Products, Competitors, Financials, Employees, …
Stimuliver focuses on developing regenerative medicines for severe liver diseases within the biotechnology sector. Use the CB Insights Platform to explore Stimuliver's full profile. ...See details»
Stimuliver Company Profile 2024: Valuation, Funding & Investors
Stimuliver General Information Description. Developer of a disruptive liver implant technology intended to treat critically failing liver function in humans. The company is developing liver …See details»
Stimuliver raises DKK 15m to develop remote stem cell therapy for …
May 28, 2019 Stimuliver. David Hay, CEO. [email protected]. NOTES TO EDITORS. About Stimuliver. Stimuliver is a Danish biotech company with technology from the University of …See details»
Stimuliver - Funding, Financials, Valuation & Investors - Crunchbase
Oct 7, 2021 Stimuliver is a biotechnology company developing a 3D liver implant to treat critically failing liver function. Search Crunchbase. Start Free Trial . Chrome Extension. ... How …See details»
Liver implant start-up Stimuliver launched | Centre of Regenerative ...
Sep 14, 2021 Stimuliver is developing a liver implant which uses lab engineered liver tissue that will be placed underneath the skin to 'top up' the patient's reduced liver function. The company …See details»
Stimuliver on LinkedIn: #celltherapy #biotechinnovation #stemcells ...
Stimuliver is a Danish biotech company with technology from The University of Edinburgh established to develop a scalable, safe and effective treatment for diseases affecting the liver. …See details»
Contact — Stimuliver
EMAIL [email protected] PHONE +45 5055 2648 ADDRESS Ole Maaløes Vej 3, 3 2200 Copenhagen DenmarkSee details»
Stimuliver on LinkedIn: Stimuliver announces further investment to ...
Stimuliver announces senior cell therapy executive to be joining the board. Copenhagen, Denmark, 2024 – Stimuliver APS is an emerging biotech company developing a first-in-class …See details»
Stimuliver Announces Their Scientific Advisory Board
May 28, 2019 Stimuliver Announces Their Scientific Advisory BoardSee details»
Stimuliver is enrolled into BioInnovation Institute’s Venture Lab ...
May 28, 2019 Giles Dudley, Portfolio Manager at BioInnovation Institute, says the following about Stimuliver: “Stimuliver is built on world-class research, and we are delighted to work with …See details»